Kazia Therapeutics Limited is seeking various regulatory designations from the FDA to support its drug development pipeline.
6 reports, 1 independent
Updated Sep 9
Gone quiet
Reached 6 outlets in its first 24 hours
- Reports
- 6
- Developments
- 1
- Repetition
- 83%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kazia Therapeutics Limited is seeking various regulatory designations from the FDA to support its drug development pipeline.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- The FDA and Intellia Therapeutics are preparing a regulatory filing for product approval.
- The FDA and European Medicines Agency are harmonizing regulatory review of drug applications.
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.
- Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.
- FDA and Pfizer are seeking regulatory approval for their products.